SEC Form 4 · accession 0001171843-18-007354
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Hague
Officer — Chief Commercial Officer
Period of report
Oct 26, 2018
Accepted (ET)
Oct 30, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 26, 2018 | F | 1,546 | $35.55 | D | 22,104 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects an aggregate of 1,546 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested on October 26, 2018.